Primary Record
Sivelestat
- In stock
- 6,875 g
- Purity
- 98.8 %
- CAS
- 127373-66-4
Compound Identifiers & Properties
- CAS
- 127373-66-4
- PubChem CID
- 107706
- SMILES
- CC(C)(C)C(=O)OC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=C2C(=O)NCC(=O)O
- Canonical SMILES
- CC(C)(C)C(=O)Oc1ccc(S(=O)(=O)Nc2ccccc2C(=O)NCC(=O)O)cc1
Names & Synonyms
- Sivelestat
- Adalimumab
- 127373-66-4
- Elaspol
- siberestat
- sivelestatum
- Ono-5046
- Silvelestat
- Sivelastat
- Sivelestat sodium
- Sivelestat [USAN]
- Sivelestat RS
- Elastase Inhibitor IV
- sivelestate sodium
- ABT-D2E7
- Sivelestat [USAN:INN]
- SIVELESTAT [MI]
- Ono 5046
- sivelestat sodium hydrate
- C20H22N2O7S
- Ono-EI-600
- ONO-5046.Na
- SIVELESTAT [INN]
- ONO5046
- RefChem:931817
- Sivelestat (ONO-5046)
- Sivelestat (USAN/INN)
- DWI62G0P59
- UNII-DWI62G0P59
- UNII-FYS6T7F842
- DTXSID9048304
- CHEMBL76688
- D0FT4R
- AC1L32LG
- SIVELESTAT [MART.]
- LY544349
- EI546
- SIVELESTAT [WHO-DD]
- MFCD00889071
- Adalimumab (anti-TNF-alpha)
- US9073833, Sivelestat
- SCHEMBL123221
- Sivelestat sodium salt hydrate
- EI 546
- GTPL6441
- orb1146474
- orb1300286
- 2-[[2-[[4-(2,2-dimethylpropanoyloxy)phenyl]sulfonylamino]benzoyl]amino]acetic acid
- DTXCID7028279
- SCHEMBL28751433
- CTK8F0808
- sivelestat(anhydrous, free acid)
- LY-544349
- WLZ4525
- BTGNGJJLZOIYID-UHFFFAOYSA-N
- CHEBI:135704
- BDBM166439
- HMS3753M09
- HMS5086O07
- 331731-18-1
- Adalimumab pound 54mg/ml pound(c)
- BCP09708
- KS-000002IP
- LY 544349
- tert-butyl4-oxocyclohexanecarboxylate
- BDBM50084637
- C20-H22-N2-O7-S
- CID107706
- EI-546
- IN1349
- s8136
- ZINC21298097
- AKOS022176173
- ACN-040209
- CCG-269065
- CID:107706
- CS-2919
- DB12863
- QC-5742
- SDCCGSBI-0633759.P001
- EI546;LY544349;ONO5046
- NCGC00263570-02
- NCGC00263570-03
- NCGC00263570-06
- NCGC00346934-01
- AN-32579
- AS-74843
- FS170937
- HY-17443
- P528
- SC-92389
- SID:76715600
- N-(2-(4-(2,2-Dimethylpropionyloxy)phenylsulfonylamino)benzoyl)aminoacetic acid
- J464.383F
- LS-172679
- RT-012672
- 5134A
- NS00071648
- ONO5046;LY544349;EI546
- A11497
- A14184
- D03788
- Elastase Inhibitor IV - CAS 127373-66-4
- N-(o-(p-Pivaloyloxybenzene)sulfonylaminobenzoyl)glycine
- Propanoic acid, 2,2-dimethyl-, 4-[[[2-[[(carboxymethyl)amino]carbonyl]phenyl]amino]sulfonyl]phenyl ester
- (2-((4-(Pivaloyloxy)phenyl)sulfonamido)benzoyl)glycine
- 373S664
- A857463
- C069195
- Glycine, N-(2-(((4-(2,2-dimethyl-1-oxopropoxy)phenyl)sulfonyl)amino)benzoyl)-
- Q5646925
- BRD-K02152879-414-01-3
- BRD-K02152879-414-02-1
- o-(p-Hydroxybenzenesulfonamido)hippuric acid, pivalate (ester)
- N-[o-(p-pivaloyloxybenzene)sulfonylaminobenzoyl]glycine
- 2-[(2-{4-[(2,2-dimethylpropanoyl)oxy]benzenesulfonamido}phenyl)formamido]acetic acid
- 2-(2-(4-(pivaloyloxy)phenylsulfonamido)benzamido)acetic acid
- 201677-61-4
- N-[2-[[[4-(2,2-Dimethyl-1-oxopropoxy)phenyl]sulfonyl]amino]benzoyl]glycine
- 2-[[2-[(4-pivaloyloxyphenyl)sulfonylamino]benzoyl]amino]acetic acid
- N-(2-{4-[(2,2-Dimethylpropanoyl)oxy]benzene-1-sulfonamido}benzoyl)glycine
- 2,2-Dimethyl-propionic acid 4-[2-(carboxymethyl-carbamoyl)-phenylsulfamoyl]-phenyl ester
- 2-((2-((4-(2,2-dimethylpropanoyloxy)phenyl)sulfonylamino)benzoyl)amino)acetic acid
- 2-((2-(4-((2,2-dimethylpropanoyl)oxy)benzenesulfonamido)phenyl)formamido)acetic acid
- 2-[[2-[[[4-[(2,2-Dimethylpropionyl)oxy]phenyl]sulfonyl]amino]benzoyl]amino]acetic acid
- 2-[[2-[[4-(2,2-dimethylpropanoyloxy)phenyl]sulfonylamino]phenyl]carbonylamino]ethanoic acid
- 2-[2-[4-(2,2-Dimethylpropanoyloxy)phenylsulfonylamino]benzoylamino]acetic acid
- N-(2-(((4-(2,2-Dimethyl-1-oxopropoxy)phenyl)sulfonyl)amino)benzoyl)glycine
- N-[2-(N'-(Carboxymethyl)-aminocarbonyl)-phenyl]-4-t-butylcarbonyloxybenzenesulfonamide
- N-[2-[[4-[(2,2-Dimethylpropionyl)oxy]phenyl]sulfonylamino]benzoyl]aminoacetic acid
- 2,2-Dimethyl-propionic acid 4-[2-(carboxymethyl-carbamoyl)-phenylsulfamoyl]-phenyl ester(ONO-5046)
- 2,2-Dimethylpropanoic acid 4-[[[2-[(carboxymethyl)aminocarbonyl]phenyl]amino]sulfonyl]phenyl ester
- 37697-64-6
- ONO-5046|||2-[[2-[[4-(2,2-Dimethylpropanoyloxy)phenyl]sulfonylamino]benzoyl]amino]acetic acid